What are the common signs and symptoms associated with subdermal contraceptive implants in female patients of reproductive age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Subdermal Contraceptive Implants

The most common signs and symptoms of subdermal contraceptive implants are menstrual bleeding changes (affecting up to 80% of users), including amenorrhea (22%), infrequent bleeding (34%), frequent bleeding (7%), and prolonged bleeding (18%), along with systemic effects such as weight gain (55%), acne, breast tenderness, and headache. 1, 2, 3

Menstrual Bleeding Pattern Changes

Expected Bleeding Irregularities

  • Amenorrhea occurs in approximately 22% of users and is generally not harmful, requiring only reassurance rather than treatment 1, 4, 3
  • Infrequent bleeding or spotting affects about 34% of women throughout implant use 5, 3
  • Frequent bleeding occurs in 6.7% of users 3
  • Prolonged bleeding affects 17.7% of users 3
  • Unscheduled spotting or light bleeding is most common during the first year and typically decreases with continued use 1, 5

Predictive Pattern

  • The bleeding pattern experienced during the first three months broadly predicts future patterns for most women 3
  • Women with favorable bleeding patterns in the initial phase tend to continue with this pattern throughout the first two years 3
  • Women with unfavorable initial patterns have at least a 50% chance that the pattern will improve over time 3

Systemic Adverse Effects

Common Symptoms

  • Weight gain is the most frequently reported systemic side effect, affecting approximately 55% of users 2, 6, 7
  • Acne is frequently reported 2, 7
  • Breast tenderness is commonly experienced 2
  • Headache occurs in a significant proportion of users 7
  • Dizziness and mood disturbances may occur 7
  • Nausea and lower abdominal pain are possible 7
  • Hair loss and loss of libido have been reported 7

Beneficial Effects

  • Approximately 77% of women with baseline dysmenorrhea experience complete resolution of menstrual pain symptoms 3

Local Insertion Site Effects

  • Pain at the implant site may occur 7
  • Neuropathy has been reported in rare cases 7
  • There is a small risk of pelvic infection limited to the first 20-21 days after insertion 2

Critical Clinical Pitfalls to Avoid

When Bleeding Changes Occur

  • Always rule out pregnancy if a woman's regular bleeding pattern changes abruptly to amenorrhea 4
  • Systematically evaluate for pregnancy, medication interactions, sexually transmitted diseases, and new pathologic uterine conditions (polyps, fibroids) before attributing all bleeding to the implant 5
  • Consider screening for STIs, particularly in adolescents, when unscheduled bleeding occurs 2

Counseling Importance

  • Provide comprehensive pre-insertion counseling about expected bleeding patterns to reduce discontinuation rates 1, 2, 3
  • Explain that bleeding changes are generally not harmful and may or may not decrease with continued use 1, 5
  • Advise women to return at any time to discuss side effects or if they want to change methods 1

Discontinuation Rates

  • Only 11.3% of patients discontinue due to bleeding irregularities, mainly because of prolonged flow and frequent irregular bleeding 3
  • Approximately 9% of women stop using implants during the first year, with menstrual problems being the main reason 8
  • Despite experiencing side effects, most women remove the implant only when it reaches the end of its contraceptive duration (43%) 6

Follow-Up Recommendations

  • No routine follow-up visit is required after insertion 1
  • At routine visits, assess satisfaction with the method, any concerns about use, and changes in health status that would affect appropriateness of continued use 1
  • Consider assessing weight changes and counseling women concerned about perceived weight gain associated with their method 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Mirena Adverse Drug Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The effects of Implanon on menstrual bleeding patterns.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2008

Guideline

Manejo de Amenorrea Secundaria en Pacientes con Implante Subdérmico

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Vaginal Spotting After One Year of Implanon Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Subdermal contraceptive implants.

The Journal of steroid biochemistry and molecular biology, 1995

Related Questions

Should a subdermal (under the skin) contraceptive implant be removed in a female patient of reproductive age due to severe side effects?
Can a subdermal (under the skin) implant be placed on the same day as the removal of another implant?
What are the criteria for removing a subdermal contraceptive implant before its expected lifespan?
When should I start using the injectable hormonal contraceptive (e.g. Depo-Provera (medroxyprogesterone acetate)) after removing the subdermal implantable contraceptive?
How long will a subdermal implant (containing etonogestrel), such as Nexplanon (etonogestrel), remain effective in a female of reproductive age with no specified medical history if removed before its due date?
Can hydrochlorothiazide (thiazide diuretic) cause hypokalemia, especially in patients with pre-existing kidney issues, the elderly, or those with a history of electrolyte imbalances?
What is the best anticoagulant treatment for a newly developed deep vein thrombosis (DVT) in an adult patient with normal renal function and elevated body mass index (BMI), who has failed dabigatran (Pradaxa) treatment?
What should be done if someone is bitten or scratched by a rabid bandicoot rat?
What is the recommended palliative chemotherapy regimen for a patient with advanced or metastatic gastric (stomach) cancer?
What is the expected behavior of an ill or injured bandicoot rat patient?
What tumor markers should be obtained for a patient with biliary ectasia, specifically to monitor for potential malignancies such as cholangiocarcinoma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.